---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-098758"
form_type: "8-K"
ticker: "ASRT"
cik: "0001808665"
company_name: "Assertio Holdings, Inc."
filed_at: "2025-10-10T23:59:59+00:00"
generated_at: "2026-05-17T04:05:38.254016+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Assertio, Hanmi amend ROLVEDON supply agreement; price cut mid-single digits

## Summary
- Mid-single-digit price reduction on ROLVEDON drug substance from Hanmi, fixed through license term.
- Supplier may request price increases from 2028 if costs rise above threshold.
- Per-gram pricing decreases if global ROLVEDON volume exceeds unmet threshold.
- Spectrum must provide annual forecast; at least 50% of forecasted orders binding.
- No minimum purchase requirements; Spectrum may negotiate lower price if process cuts costs.

## SEC filing metadata
- accession: 0001104659-25-098758
- form_type: 8-K
- ticker: ASRT
- cik: 0001808665
- company_name: Assertio Holdings, Inc.
- filed_at: 2025-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/0001104659-25-098758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808665/000110465925098758/tm2528497d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-098758
- JSON: https://secwatch.observer/filing/0001104659-25-098758.json
- Plain text: https://secwatch.observer/filing/0001104659-25-098758.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.